• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD ANGIOCATH¿ PLUS 18 G X 1.16 IN.; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD ANGIOCATH¿ PLUS 18 G X 1.16 IN.; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 382444
Device Problem Break (1069)
Patient Problems Pain (1994); Phlebitis (2004); Swelling (2091); Foreign Body In Patient (2687)
Event Date 03/28/2017
Event Type  Injury  
Manufacturer Narrative
Medical device expiration date: unknown.(b)(6).Pma / 510(k) #: there is no 510(k) for this device as it is manufactured outside the us and not sold in the us.Device manufacture date: unknown.Results: a device evaluation is anticipated, but has not yet begun.However, the customer also returned three photos for evaluation.Phlebitis was visualized in two of the three photos.A review of the device history record could not be performed as a lot number was not provided for this incident.Conclusion: a conclusion is not yet available as the evaluation is still in process.Upon completion of the investigation, a supplemental report will be filed.Udi #: (b)(4).
 
Event Description
It was reported that a bd angiocath¿ plus 18 g x 1.16 in.Was used for intravenous injection during a bronchoscopy.One week later, the patient complained that the injection site was swollen and painful.The patient received a ct scan of her brain, heart, and veins and a foreign body was found in one of the patient's blood vessels.It was also reported that the patient developed phlebitis because of the broken catheter.There was no report of any further medical or surgical interventions.
 
Manufacturer Narrative
Results: used fragments were returned for evaluation.The fragments were subjected to ftir testing.The ftir results showed that the spectrum of the fragments matched cellulose and does not match with the vialon and vialo-e material using in the catheter tubing.As previously reported, a review of the device history record could not be performed as a lot number was not provided for this incident.Conclusion: an absolute root cause for this incident cannot be determined as the ftir testing confirmed the returned fragments did not match the bd catheter tubing material.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ANGIOCATH¿ PLUS 18 G X 1.16 IN.
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015652845
MDR Report Key6513042
MDR Text Key73407360
Report Number8041187-2017-00036
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/21/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number382444
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/12/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received03/29/2017
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-